Merck.com - Research & Development News http://www.merck.com/newsroom/news-release-archive/research_and_development/ Merck.com - Research & Development News Merck.com - Research & Development News 142 42 http://www.merck.com/newsroom/news-release-archive/research_and_development/ http://www.merck.com/site_images/mercklogo-rss.jpg 02/07/2012 http://www.merck.com/newsroom/news-release-archive/research-and-development/2012_0207.html?src=rss 07-Feb-2012 Merck Provides Update on Development Program for Suvorexant, an Investigational Orexin Receptor Antagonist for the Treatment of Insomnia 02/02/2012 http://www.merck.com/newsroom/news-release-archive/research-and-development/2012_0206.html?src=rss 06-Feb-2012 Merck Establishes New MSD R&D Asia Headquarters 12/06/2011 http://www.merck.com/newsroom/news-release-archive/corporate/2011_1206.html?src=rss 06-Dec-2011 Data from TRACER Study of Vorapaxar, Merck's Investigational Medicine for Cardiovascular Disease, Presented at AHA and Published in NEJM 11/13/2011 http://www.merck.com/newsroom/news-release-archive/research-and-development/2011_1113.html?src=rss 13-Nov-2011 Merck Highlights Pipeline Progress and Showcases Novel Innovations at R&D and Business Briefing 11/10/2011 http://www.merck.com/newsroom/news-release-archive/research-and-development/2011_1110.html?src=rss 10-Nov-2011 FDA Accepts New Drug Application Filing for Ridaforolimus, Investigational mTOR Inhibitor FDAAcceptsNewDrug10/05/2011 http://www.merck.com/newsroom/news-release-archive/research-and-development/2011_1005.html?src=rss 05-Oct-2011 New Data on Odanacatib, Merck's Phase III Investigational Cat-K Inhibitor for Osteoporosis, Presented at the Annual Meeting of The American Society for Bone and Mineral Research NewDataonOdanacatib09/19/2011 http://www.merck.com/newsroom/news-release-archive/research-and-development/2011_0919.html?src=rss 13-September-2011 Merck and BGI Establish Strategic Collaboration Focused on Biomarkers and Genomic Technologies MerckandARIADAnnounce09/13/2011 http://www.merck.com/newsroom/news-release-archive/research-and-development/2011_0913.html?src=rss 13-September-2011 Merck and ARIAD Announce European Medicines Agency Accepts Marketing Authorization Application for Ridaforolimus, Investigational mTOR Inhibitor MerckandARIADAnnounce08/18/2011 http://www.merck.com/newsroom/news-release-archive/research-and-development/2011_0818.html?src=rss 18-August-2011 Merck to Acquire Rights to Vernakalant i.v. in Canada, Mexico and the United States from Astellas MercktoAcquire07/26/2011 http://www.merck.com/newsroom/news-release-archive/research-and-development/2011_0726.html?src=rss 26-July-2011 Merck to Participate in New Research Efforts to Eradicate HIV MercktoParticipate07/11/2011 http://www.merck.com/newsroom/news-release-archive/research-and-development/2011_0711.html?src=rss 11-July-2011 Merck and Hanwha Chemical Corporation Establish Global Strategic Collaboration to Develop and Commercialize Biosimilar Candidate MerckandHanwhaChemical06/13/2011 http://www.merck.com/newsroom/news-release-archive/research-and-development/2011_0613.html?src=rss 13-June-2011 Merck and Intercell AG Announce Termination of Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710 MerckandARIADAnnounce06/08/2011 http://www.merck.com/newsroom/news-release-archive/research-and-development/2011_0608.html?src=rss 08-June-2011 Merck and ARIAD Announce Presentation of Results of Phase III SUCCEED Trial at American Society of Clinical Oncology Annual Meeting MerckandARIADAnnounce06/06/2011 http://www.merck.com/newsroom/news-release-archive/research-and-development/2011_0606.html?src=rss 06-June-2011 Merck's Investigational Prostaglandin Analogue Ophthalmic Medication Tafluprost Meets Primary Endpoint in Phase III Study MercksInvestigational05/02/2011 http://www.merck.com/newsroom/news-release-archive/research-and-development/2011_0502.html?src=rss 02-May-2011 VICTRELIS™ (boceprevir) Unanimously Recommended for Approval by FDA Advisory Committee for Treatment of Chronic HCV Genotype 1 Infection VICTRELIS(boceprevir)04/27/2011 http://www.merck.com/newsroom/news-release-archive/research-and-development/2011_0427.html?src=rss 27-Apr-2011